AstraZeneca have initiated a Phase I/II trial of mTOR inhibitor AZD8055 in Advance Solid Tumors, Lymphoma and Endometrial Carcinoma
Filed under: kinase | Tagged: kinase, AstraZeneca, Phase II, mTOR, phase I, AZD8055, AZD-8055 | Comments Off
AstraZeneca initiate Phase I/II trial of mTOR inhibitor AZD8055
Posted on August 8, 2008 by crimsoncanary
Carna bioscience partner with Caliper for kinase profiling and assays
Posted on August 8, 2008 by crimsoncanary
Carna Biosciences have partnered with Caliper Life Sciences to supply protein kinases to expand Caliper’s kinase profiling and assay development services, and ProfilerPro Kinase Selectivity Assay Kits.
Filed under: kinase | Tagged: Assays, Caliper Life Sciences, Carna bioscience, kinase, Profiling | Comments Off
NICE recommends against Avastin, Nexavar, Sutent and Torisel for Kidney Cancer
Posted on August 8, 2008 by crimsoncanary
The UK’s National Institute for Health and Clinical Excellence (NICE) has made a preliminary ruling stating that Avastin, Nexavar, Sutent and Torisel are not effective enough to warrant their high cost and shouldn’t be prescribed to new patients in Britain.
Filed under: Kinase receptor, kinase | Tagged: Avastin, bayer, bevacizumab, Genentech, kinase, mTOR, multikinase, Nexavar, onyx, Pfizer, regulatory, Roche, sorafenib, SU-11248, SU11248, sunitinib, sutent, temsirolimus, torisel, VEGF, Wyeth | Comments Off
